← Leaderboards
Joseph H Oved
Sloan-Kettering Inst Can Research
$2,595,642
Attributed
$2,595,642
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
FDA$2,595,642 · 2
By mechanism
R01$2,595,642 · 2
Top collaborators
No co-investigators on record.
Grant awards (4)
Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia$650,000
R01 · FY2025 · FD · contact PI
Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia$650,000
R01 · FY2024 · FD · contact PI
Phase 2 Bridging Pre-transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)$647,533
R01 · FY2024 · FD · contact PI
Phase 2 Bridging Pre-transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)$648,109
R01 · FY2023 · FD · contact PI